Insuficiencia cardiaca aguda

  1. M. Gallego Alonso-Colmenares 1
  2. J. Fernández Herranz 1
  3. M. Jiménez Lucena 1
  4. S. Gordo Remartínez 1
  1. 1 Servicio de Urgencias. Hospital General Universitario Gregorio Marañón
Revue:
Medicine: Programa de Formación Médica Continuada Acreditado

ISSN: 0304-5412

Année de publication: 2015

Titre de la publication: Urgencias: Urgencias cardiovascualares. Reanimación cardiopulmonar

Serie: 11

Número: 87

Pages: 5201-5208

Type: Article

DOI: 10.1016/J.MED.2015.09.013 DIALNET GOOGLE SCHOLAR

D'autres publications dans: Medicine: Programa de Formación Médica Continuada Acreditado

Objectifs de Développement Durable

Résumé

Heart failure is a disease whose prevalence is increasing. It is the most frequent cause of hospitalization in the elderly population. In the Emergency Department heart failure it may appear as a new situation or a worsening of an existing process. There is a profile of patients in which the diagnosis is simple; however, when the most typical symptoms are absent diagnosis is a challenge for clinicians. We must always maintain a high level of suspicion and use the tools in our hands as natriuretic peptides and the cardiac ultrasound and lung that have actually revolutionized the diagnosis of heart failure in the emergency services. Treatment of acute heart failure has changed little in recent years. We have studied many new drugs that have found their place in very specific situations but have not significantly changed the picture of acute heart failure.

Références bibliographiques

  • McMurray JJ, Adamopoulos S, Anker SD, Auricchio A, Böhm M, Dickstein K, et al. ESC Committee for Practice Guidelines. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosisi and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur Heart J. 2012;33:1787-847.
  • Banegas JR, Rodríguez Artalejo F, Guallar-Castillón P. Situación epidemiologica de la insuficiencia cardiaca en España. Rev Esp Car-diol. 2006;6(3):4-9.
  • Llorens P, Escoda R, Miró O, Herrero-Puente P, Martín-Sánchez FJ, Ja-cob J, et al. Características clínicas, terapéuticas y evolutivas de los pacien-tes con insuficiencia cardiaca aguda atendidos en servicios de urgencias españoles: Registro EAHFE (Epidemiology of Acute Heart Failure in Spanish Emergency Departments). Emergencias. 2015;27:11-22.
  • Laribi S, Aouba A, Nikolaou M, Lassus J, Cohen-Solal A, Plaisance P, et al.; GREAT network. Trends in death attributed to heart failure over the past two decades in Europe. Eur J Heart Fail. 2012;14:234-9.
  • Januzzi JL Jr, Camargo CA, Anwaruddin S, Baggish AL, Chen AA, Krau-ser DG, et al. The N-terminal pro-BNP investigation of dyspnea in the emergency department (PRIDE) study. Am J Cardiol. 2005;95(8):948-54.
  • Marti CN, Georgiopoulou VV, Kalogeropoulos AP. Acute heart failure: patient characteristics and pathophysiology. Curr Heart Fail Rep. 2013; 10(4):427-33.
  • Jacob Rodríguez J, Herrero Puente P, Martín Sánchez FJ, Llorens P, Miró O, Perelló R; en representación de los miembros del grupo ICA-SEMES. Estudio ECO-EAHFE: análisis de los pacientes con ecocardiografía rea-lizada previamente a una visita en urgencias por episodio de insuficiencia cardiaca aguda. Rev Clin Esp. 2011;211(7):329-37.
  • Pivetta E, Goffi A, Lupia E, Tizzani M, Porrino G, Ferreri E, et al.; SIMEU Group for Lung Ultrasound in the Emergency De-partment in Piedmont. Lung ultrasound-implemented diagnosis of acute decompensated heart failure in the ED: A SIMEU multicenter study. Chest. 2015;148:202-10.
  • Nohria A, Tsang SW, Fang JC, Lewis EF, Jarcho JA, Mudge GH, et al. Clinical assessment identifies hemodynamic profiles that predict outco-mes in patients admitted with heart failure. J Am Coll Cardiol. 2003; 41:1797-804.10.
  • Nieminen MS, Böhm M, Cowie MR, Drexler H, Filippatos GS, Jondeau G, et al. ESC Committee for Practice Guideline (CPG). Executive sum-mary of the guidelines on the diagnosis and treatment ot acute heart failure: the Task Force on Acute Heart Failure of the European Society of Cardiology. Eur Heart J. 2005;26:384-416.
  • Masip J, Roque M, Sánchez B, Fernández R, Subirana M, Expósito JA. Noninvasive ventilation in acute cardiogenic pulmonary edema: systema-tic review and meta-analysis. JAMA. 2005;294(24):3124-30.
  • Salman A, Milbrandt EB, Pinsky MR. The role of noninvasive ventilation in acute cardiogenic pulmonary edema. Crit Care. 2010;14(2):303.
  • Mariani J, Macchia A, Belziti C, Deabreu M, Gagliardi J, Doval H, et al. Noninvasive ventilation in acute cardiogenic pulmonary edema: a meta-analysis of randomized controlled trials. J Card Fail. 2011;17(10):850-9.
  • Carratala JM, Masip J. Ventilación no invasiva en la insuficiencia cardiaca aguda: uso de CPAP en los servicios de urgencias. Emergencias. 2010;22: 49-55.
  • Parke RL, McGuinness SP, Eccleston ML. A preliminary rando-mized controlled trial to assess effectiveness of nasal high-flow oxygen in intensive care patients. Respir Care. 2011;56(3):265-70.
  • Shah RA, Subban V, Lakshmanan A, Varayanan S, Udhayakumaran K, Pakshirajan B, et al. A prospective, randomized study to evaluate the effi-cacy of various diuretic strategies in acute decompensated heart failure. Indian Heart J. 2014;66(3):309-16.
  • Salvador DR, Rey NR, Ramos GC, Punzalan FE. Continuous infusion versus bolus inyection of loop diuretics in congestive heart failure. Cochrane Database Syst Rev. 2005;(3):CD003178.
  • Peacock WF, Hollander JE, Diercks DB, Lopatin M, Fonarow G, Emer-man CL. Morphine and outcomes in acute decompensated heart failure: an ADHERE analysis. Emerg Med J. 2008;25:205-9.
  • O’Connor CM, Starling RC, Hernandez AF, Armstrong PW, Dickstein K, Hasselblad V, et al. Effect of nesiritide in patients with acute decompensated heart failure. N Engl J Med. 2011;365:32-43.
  • Abraham WT, Adams KF, Fonarow GC, Costanzo MR, Berkowitz RL, LeJemtel TH, et al.; ADHERE Scientific Advisory Committee and Inves-tigators; ADHERE Study Group. In-hospital mortality in patients with acute decompensated heart failure requiring intravenous vasoactive me-dications. An analysis from the acute decompensated. Heart Failure Na-tional Registry (ADHERE). J Am Coll Cardiol. 2005;46(1):57-64.
  • Packer M, Colucci W, Fisher L, Massie BM, Teerlink JR, Young J, et al.; REVIVE Heart Failure Study Group. Effect of levosimendan on the short-term clinical course of patients with acutely decompensated heart failure. JCHF. 2013;1(2):103-11.
  • De Backer D, Biston P, Devriendt J, Madl C, Chochrad D, Aldecoa C, et al. Comparison of dopamine and norepinephrine in the treatment of shock. N Engl J Med. 2010;362:779-89.
  • Peura JL, Colvin-Adams M, Francis GS, Grady KL, Hoffman TM, Jessup M, et al. Recommendations for the use of mechanical circulatory support: device strategies and patient selection: a scientific statement from the American Heart Association. Circulation. 2012;126:2648-67.
  • Miró O, Llorens P, Martín-Sánchez FJ, Herrero P, Pavón J, Pé-rez-Durá MJ, et al. Short-term prognostic factors in elderly patients seen in emergency departments for acute heart failure. Rev Esp Cardiol. 2009;62(7):757-64.
La source de données: Dialnet